Rania Mahmoud Abdel Ghani
Faisal, Giza Governorate, 12944, Egypt
NCT Number: NCT04548102
Up till now, there is insufficient evidence that daily fetal movement counting for pregnant women who are already have a history of high risk pregnancy is beneficial or not in term of early detection and preventing adverse pregnancy outcomes.
Aim The aim of the current study is to evaluate the effect of fetal movement counting on maternal and fetal outcome
Looking for future studies?
Notify MeThe researchers met the pregnant women in antenatal clinics during their routine follow up. Woman who was eligible to be recruited in the study signed the consent after description of the study's purpose. Pregnant women in the study group received verbal information regarding normal fetal movements (i.e. description of the changing pattern of movement as the fetus develops, normal sleep/wake cycles, and factors which may modify the mother's perception of movements such as maternal weight and placental position), and its importance to be followed during the third trimester. Further, each pregnant woman in the study group was trained how to count the fetal movement (i.e.lying down on her left side after taking her meal, and concentrating on fetal movements, calculate it three times per day, half an hour/ one time and record it in the chart). As a rule, if there are less than 10 movements felt in 2 hours, women should contact her health care provider immediately (Royal college of obstetrician & gynecologists, 2011). Fetal movements counting chart was provided and women telephoned once a week in order to ensure proper recording. They also asked to present the fetal movements' chart to the researcher and thier health care providers in each antenatal follow up visit. Pregnant women in both groups; the study and the control groups followed according to thier antenatal visits schedule till delivery. Women in the control group received the antenatal hospital standard care. The maternal and neonatal outcomes had been assessed at delivery unit.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Pregnant women in the study group received verbal information regarding normal fetal movements (i.e. description of the changing pattern of movement as the fetus develops, normal sleep/wake cycles, and factors which may modify the mother's perception of movements such as maternal weight and placental position), and its importance to be followed during the third trimester. A chart for fetal movements counting provided and to ensure proper performance of this task, women telephoned once a week. They also asked to show the fetal movements chart to the researcher and the health care providers in each visit. Women followed according to her antenatal visits schedule till delivery.
Time frame: 37 weeks gestation
Mothers' self report
Time frame: 37 weeks gestation
Antenatal follow up and examination
Time frame: Within 24 hoursafter delivery
Deliver died fetus or died within 24hrs. after delivery
Time frame: 10 minutes after delivery
Newborn Apgar at fifth minutes less than 6
Time frame: 37 weeks gestation
Any progress in mothers' medical conditions that affect thier pregnancy outcomes
Time frame: Immediatly after delivery
Mode of delivery and delivery complications
Cairo University
Other
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07124325
Cardiotocography, High Risk
Birmingham, United Kingdom
View Trial DetailsNCT05647252
Elective Surgery, High Risk
Zurich, Canton of Zurich, Switzerland
View Trial DetailsNCT04614363
Genital Diseases, Genital Diseases, Male
Houston, Texas, United States
View Trial DetailsNCT01030861
Autoantibody Positive, Autoimmune Diseases
San Francisco, California, United States
View Trial Details